Global Normal Saline for Parenteral Use Market Insights Forecasts to 2033

• The Global Normal Saline for Parenteral Use Market Size Was Estimated at USD 3.38 Billion in 2023
• The Market Size is Expected to Grow at a CAGR of around 6.84% from 2023 to 2033
• The Worldwide Normal Saline for Parenteral Use Market Size is Expected to Reach USD 6.55 Billion by 2033
• Asia Pacific is expected to grow at the fastest region during the forecast period.

The Global Normal Saline for Parenteral Use Market Size is anticipated to exceed USD 6.55 Billion by 2033, growing at a CAGR of 6.84% from 2023 to 2033.  The market expansion is attributed to the larger size of an aging population, increasing prevalence of chronic diseases, up-surge in surgeries, and enlargements of the healthcare infrastructure with the provision of medical supplies.

Market Overview            

The normal saline for parenteral use market involves the production and distribution of 0.9% sodium chloride solution, essential for intravenous and intramuscular injections, medication dilution, and maintaining vascular access in patients. Normal saline, also known as 0.9% sodium chloride solution, is a sterile solution of sodium chloride in water, suitable for various medical applications. It helps maintain electrolyte levels, nerve function, muscle contraction, and cellular homeostasis. The global normal saline market for parenteral use is growing due to increased demand during surgeries, fluid management, and postoperative recovery. It is also used in chronic diseases to maintain hydration and medication administration. Strategic collaborations between healthcare providers, pharmaceutical companies, and medical device manufacturers aim to enhance product innovation and patient care outcomes. Normal saline is a crystalloid fluid consumed in the medical sectors and pharmaceutical industries in the manufacturing of parenteral formulations. For adults and pediatric populations suffering from hydration and electrolyte disturbances normal saline is preferred with concentrations of 0.9% and 0.45%. The market is expanding as a result of developments in intravenous therapeutic methods and medical technology.

Report Coverage

This research report categorizes the global normal saline for parenteral use market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global normal saline for parenteral use market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global normal saline for parenteral use market.

Driving Factors

The increasing prevalence of chronic diseases like diabetes, hypertension, and kidney disorders has increased the demand for normal saline for hydration, electrolyte balance, and medication administration. The rise in surgical procedures necessitates a reliable supply of normal saline for pre-operative, intra-operative, and post-operative care. Expanding healthcare infrastructure and the aging population also drive demand for normal saline, especially for elderly individuals. Saline is the most commonly used IV fluid globally for managing conditions like dehydration, vomiting, diarrhea, and critical conditions. 0.9% NaCl is the most commonly used, especially in neonates for managing sepsis, hyponatremia, hypernatremia, and fluid imbalances.

Restraining Factors

The production and distribution of normal saline are subject to rigorous regulatory guidelines, requiring manufacturers to adhere to complex and costly compliance processes.

Market Segmentation

The global normal saline for parenteral use market share is classified into type and application.

• The plastic bottles accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the projected timeframe.

Based on the type, the global normal saline for parenteral use market is categorized as glass bottles and plastic bottles. Among these, the plastic bottles accounted for the largest share in 2023 and is expected to grow at a significant share during the projected timeframe. The segmental expansion is owing to its lightweight, ease of the handle during transportation, less prone to breakage, longer durability, rising commercial agreements for IV fluids, single usability reduced contamination, no risk of an accident while carrying in hospital and clinical environments, resistant to corrosion, availability, and cost-effective.

• The intravenous injection segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the estimated period.

Based on the application, the global normal saline for parenteral use market is categorized as intravenous injection and intramuscular injection. Among these, the intravenous injection segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the estimated period. This segment growth is attributed to its electrolyte balance activity, greater pharmacokinetic properties including good stability, 100% bioavailability, extensively used in hospitals for medicine delivery and fluid replacement, increase in vomiting, diarrhea, and food poisoning, and mostly preferred route of administration.

Regional Segment Analysis of the Global Normal Saline for Parenteral Use Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global normal saline for parenteral use market over the predicted timeframe.

North America is anticipated to hold the largest share of the global normal saline for parenteral use market over the predicted timeframe. North America's aging population, chronic diseases, and surgical procedures drive demand for medical supplies, driving regional growth and stocking up on essential supplies.

Asia Pacific is expected to be the fastest-growing region of the global normal saline for parenteral use market during the forecast period. The population growth, aging populations, and the epidemiological shift toward non-communicable diseases all contribute to the increased demand for normal saline for parenteral use in APAC countries, propelling the market's expansion.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global normal saline for parenteral use market along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Double Crane Pharmaceutical
• Otsuka Pharmaceutical Co. Ltd
• Cisen Pharmaceutical Co. Ltd.
• Baxter International Inc.
• Nirma Limited
• Advacrae LLC
• Pfizer
• Kelun Group
• Fresenius Kabi AG
• SSY Group Limited
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Development

• In July 2024, Amneal Pharmaceuticals Inc., obtained New Drug Application (NDA) approval from the U.S Food and Drug Administration (FDA) for its new formulation of potassium phosphates in 0.9% Sodium Chloride Injection intravenous (IV) ready-to-use (RTU) bags. It minimizes the compounding steps usually needed by clinicians when administering the products.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global normal saline for parenteral use market based on the below-mentioned segments:

Global Normal Saline for Parenteral Use Market, By Type

• Plastic Bottles
• Glass Bottles

Global Normal Saline for Parenteral Use Market, By Application

• Intramuscular Injection
• Intravenous Injection

Global Normal Saline for Parenteral Use Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa